Structural contributions of antipsychotic drugs to their therapeutic profiles and metabolic side effects

Aripiprazole in schizophrenia and schizoaffective disorder: A review

(2010) Emmanuel Stip et al.   CLINICAL THERAPEUTICS

Antipsychotic medication, functional outcome and quality of life in schizophrenia: focus on amisulpride

(2010) Philippe Nuss et al.   CURRENT MEDICAL RESEARCH AND OPINION

Behavioral Indices in Antipsychotic Drug Discovery

(2010) R. D. Porsolt et al.   JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS

Antipsychotics Associated with the Development of Type 2 Diabetes in Antipsychotic-Naïve Schizophrenia Patients

(2010) Jimmi Nielsen et al.   NEUROPSYCHOPHARMACOLOGY

Potential mechanisms of atypical antipsychotic-induced metabolic derangement: Clues for understanding obesity and novel drug design

(2010) Roberto Coccurello et al.   PHARMACOLOGY & THERAPEUTICS

Effects of Oral Ziprasidone and Oral Haloperidol on QTc Interval in Patients with Schizophrenia or Schizoaffective Disorder

(2010) Jeffrey J Miceli et al.   PHARMACOTHERAPY

Changes in weight and body mass index during treatment with melperone, clozapine and typical neuroleptics

(2010) William V. Bobo et al.   PSYCHIATRY RESEARCH

Effectiveness of clozapine, haloperidol and chlorpromazine in schizophrenia during a five-year period

(2009) Dragan B. Ravanic et al.   ARQUIVOS DE NEURO-PSIQUIATRIA

Quetiapine Extended Release

(2009) Claudine M. Baldwin et al.   CNS DRUGS

Metabolic side effects of antipsychotic drug treatment – pharmacological mechanisms

(2009) Gavin P Reynolds et al.   PHARMACOLOGY & THERAPEUTICS

Haloperidol mais prometazina para pacientes agitados - uma revisão sistemática

(2009) Gisele Huf et al.   REVISTA BRASILEIRA DE PSIQUIATRIA

The Dopamine Hypothesis of Schizophrenia: Version III--The Final Common Pathway

(2009) O. D. Howes et al.   SCHIZOPHRENIA BULLETIN

Association of adiponectin and metabolic syndrome among patients taking atypical antipsychotics for schizophrenia: A cohort study

(2009) Ya Mei Bai et al.   SCHIZOPHRENIA RESEARCH

Weight effects associated with antipsychotics: A comprehensive database analysis

(2009) Bruce Parsons et al.   SCHIZOPHRENIA RESEARCH

An Exploration of the Effect of Modafinil on Olanzapine Associated Weight Gain in Normal Human Subjects

(2008) James L. Roerig et al.   BIOLOGICAL PSYCHIATRY

Upcoming Agents for the Treatment of Schizophrenia

(2008) Delia Bishara et al.   DRUGS

Olanzapine (LY170053, 2-Methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5] Benzodiazepine), but Not the Novel Atypical Antipsychotic ST2472 (9-Piperazin-1-ylpyrrolo[2,1-b][1,3]benzothiazepine), Chronic Administration Induces Weight Gain, Hyperphagia, and Metabolic Dysregulation in Mice

(2008) R. Coccurello et al.   JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS

Short- and long-term effects of antipsychotic drug treatment on weight gain and H1 receptor expression

(2008) Mei Han et al.   PSYCHONEUROENDOCRINOLOGY